Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AEON
AEON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AEON News
AEON Biopharma Reports Increased Losses in FY Earnings
2d ago
seekingalpha
AEON Biopharma Reports Positive Developments in Biosimilar Program
2d ago
Newsfilter
AEON Biopharma Reports 2025 Financial Loss Amid Strategic Developments
1d ago
NASDAQ.COM
Biotech Landscape Update: Regulatory Approvals and Mergers
5d ago
NASDAQ.COM
AEON Biopharma Receives Positive FDA Feedback
6d ago
NASDAQ.COM
AEON Biopharma Receives Positive FDA Feedback
Mar 25 2026
Newsfilter
AEON Biopharma Appoints New CFO
Mar 09 2026
seekingalpha
AEON Biopharma Holds FDA BPD Meeting, Secures $22 Million Financing
Jan 22 2026
NASDAQ.COM
AEON Biopharma Holds FDA BPD Meeting, Shareholders Approve PIPE Financing
Jan 21 2026
Newsfilter
AEON Biopharma Grants 392,158 RSUs to New Employees
Dec 19 2025
Globenewswire
AEON Biopharma Grants 392,158 Restricted Stock Units to New Employees
Dec 19 2025
Newsfilter
AEON and Daewoong Pharmaceutical Finalize $15 Million Debt Exchange Agreement
Dec 15 2025
Globenewswire
AEON and Daewoong Pharmaceutical Finalize $15 Million Debt Exchange Agreement
Dec 15 2025
Newsfilter
AEON Biopharma Completes First PIPE Closing, Raising Approximately $1.79 Million
Nov 24 2025
Newsfilter
Aegis Capital Affirms Buy Rating for AEON Biopharma, Keeps $7.2 Price Target Intact
Oct 08 2025
Benzinga
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
May 23 2025
Newsfilter
Show More News
